Mylan Drops Appeal In Generic Paxil Contract Fight

Law360, New York (November 2, 2010, 5:11 PM EDT) -- Mylan Inc. has dropped its nascent appeal of a judge's refusal to enjoin Apotex Corp. from making a copycat version of Paxil CR and entered a discovery plan to litigate its claim that a previous agreement with GlaxoSmithKline PLC gives it the exclusive right to sell a generic form of the antidepressant.

Mylan told the U.S. District Court for the District of New Jersey in a letter dated Monday that all parties had agreed to scotch the appeal and asked Magistrate Judge Lois H. Goodman to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.